Skip to content
lifestyle.luxedb.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Iterion Therapeutics
Iterion Therapeutics Announces Promising Phase 1b Data for Tegavivint in Combination with Osimertinib in First-Line EGFR-Mutated Non-Small Cell Lung Cancer
September 22, 2026
Iterion Therapeutics Strengthens Board with Additions of Manuel Aivado, MD, PhD and Bob Smith
August 12, 2026